Search

everythinglearnresearchcommunity

for

Search:↓

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.